Designed with efficiency in synthetic processes in mind, the Separation columns for HPLC category offers the HPLC column NUCLEOSHELL ® RP 18, 5 μm, 50 Mm, 3 Mm. Featuring a Reversed phase (RP) separation principle, this analytical separation column boasts a high density monomeric octadecyl (C 18 , ODS) modification that is base deactivated (BDS), ensuring superior base deactivation (BDS). With a particle size of 5 μm and a specific surface area of 90 m²/g according to BET, this column is ideal for separating basic and other ionizable analytes, including antibiotics, antidepressants, anti-inflammatory drugs, herbicides, immunosuppressants, phytopharmaceuticals, and

• Category: Separation columns for HPLC
• Recommended application(s): Antibiotics Antidepressants Anti-inflammatory drugs Herbicides Immunosuppressants Phytopharmaceuticals Suitable for LC-MS
• pH stability: 1,0-11,0
• Specific surface according to BET: 90 m²/g
• Pressure stability: 600 bar
• Particle type: Core-shell, superficially porous particles (SPP)
• Phase: RP 18
• Column volume: 0.35 ml
• Pore size: 90 Å
• Interactions / retention mechanism: hydrophobic (van der Waals)
• USP listing: L1
• Column shape: Analytical separation column
• Endcapped: yes
• Temperature stability: 60 ° C
• L x Ø internal (column): 50 x 3 mm
• Separation principle: Reversed phase (RP)
• Pore volume: 0.9 ml/g
• Surface chemistry: High density monomeric octadecyl (C 18 , ODS) modification, Base deactivated (BDS)
• Eluent in column: Acetonitrile - Water
• Column type: HPLC column
• Particle size: 5 µm